Valproic acid improves second-line regimen of small cell lung carcinoma in preclinical models
about
VAC chemotherapy with valproic acid for refractory/relapsing small cell lung cancer: a phase II studyParaneoplastic limbic encephalitis in a patient with extensive disease small-cell lung cancer.Sodium Valproate Inhibits Small Cell Lung Cancer Tumor Growth on the Chicken Embryo Chorioallantoic Membrane and Reduces the p53 and EZH2 Expression.
P2860
Valproic acid improves second-line regimen of small cell lung carcinoma in preclinical models
description
2015 nî lūn-bûn
@nan
2015 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Valproic acid improves second- ...... arcinoma in preclinical models
@ast
Valproic acid improves second- ...... arcinoma in preclinical models
@en
Valproic acid improves second- ...... arcinoma in preclinical models
@nl
type
label
Valproic acid improves second- ...... arcinoma in preclinical models
@ast
Valproic acid improves second- ...... arcinoma in preclinical models
@en
Valproic acid improves second- ...... arcinoma in preclinical models
@nl
prefLabel
Valproic acid improves second- ...... arcinoma in preclinical models
@ast
Valproic acid improves second- ...... arcinoma in preclinical models
@en
Valproic acid improves second- ...... arcinoma in preclinical models
@nl
P2093
P2860
P1433
P1476
Valproic acid improves second- ...... arcinoma in preclinical models
@en
P2093
Cecilia Crisanti
Céline Mascaux
Fabian Vandermeers
Jean-Philippe Cosse
Luc Willems
Pascale Hubert
Philippe Delvenne
Steven M Albelda
Veena Kapoor
P2860
P304
00028-2015
P356
10.1183/23120541.00028-2015
P407
P577
2015-10-01T00:00:00Z